Hendrike Neh

Hendrike Neh

Auto-generated profile, based on publicly available information

Hendrike Neh

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Oral Oncology
Verified
Journal Article
Open access
SVSuzanne P.M. de Vette
Suzanne P.M. de Vette
IRIrene van Rijn-Dekker
Irene van Rijn-Dekker
LBLisa Van Den Bosch
Lisa Van Den Bosch
KKKylie Keijzer
Kylie Keijzer
HNHendrike Neh
Hendrike Neh
LDLisanne V. van Dijk
Lisanne V. van Dijk
Normal tissue complication probability (NTCP) models can be used to guide radiation therapy (RT) decisions by estimating side-effect risks pretreatment to minimize (late) side-effects. Recently, a comprehensive individual toxicity risk (CITOR) profile of NTCP models addressing common side-effects in head and neck cancer (HNC) patients was developed. This study investigates the generalizability of these models in an international setting, with different treatment approaches and side-effect assessments, promoting their integration into more widespread clinical practice. From a prospective registry study, 407 HNC patients were included who were treated with definitive RT with or without systemic therapy between 2015 and 2022. NTCP models predicting dysphagia, aspiration, xerostomia, sticky saliva, taste loss, speech problems, oral pain, and fatigue at 6 and 12 months after RT were evaluated. All side-effects were patient-rated using the MDASI-HN, except dysphagia which was reported by clinicians using the PSS-HN diet normalcy score. Model performance was appraised by discrimination (area under the curve [AUC]) and calibration. CITOR models showed moderate-to-high performance in this cohort (mean AUC = 0.67[range = 0.55-0.80], moderate-to-good calibration). NTCP models for dysphagia, xerostomia, sticky saliva, and fatigue were the top performing models. Models for aspiration, taste loss and speech problems performed moderately well, which was partly explained by lower incidences. Despite differences between the CITOR development and this evaluation cohort, including use of different side-effect scoring systems, most models exhibited moderate-to-high performance. This demonstrated that the dose-effect relations were generalizable. Therefore, this study supports further integration of these NTCP models in clinical practice.

29 September 2025 in Radiotherapy and Oncology
Verified
Journal Article
Open access
SVS.P.M. de Vette
S.P.M. de Vette
HNH. Neh
H. Neh
LHL. van der Hoek
L. van der Hoek
DMD.C. MacRae
D.C. MacRae
HCHung Chu
Hung Chu
LDL.V. van Dijk
L.V. van Dijk
Late radiation-associated dysphagia after head and neck cancer (HNC) significantly impacts patient's health and quality of life. Conventional normal tissue complication probability (NTCP) models use discrete dose parameters to predict toxicity risk but fail to fully capture the complexity of this side effect. Deep learning (DL) offers potential improvements by incorporating 3D dose data for all anatomical structures involved in swallowing. This study aims to enhance dysphagia prediction with 3D DL NTCP models compared to conventional NTCP models. A multi-institutional cohort of 1484 HNC patients was used to train and validate a 3D DL model (Residual Network) incorporating 3D dose distributions, organ-at-risk segmentations, and CT scans, with or without patient- or treatment-related data. Predictions of grade ≥ 2 dysphagia (CTCAEv4) at six months post-treatment were evaluated using area under the curve (AUC) and calibration curves. Results were compared to a conventional NTCP model based on pre-treatment dysphagia, tumour location, and mean dose to swallowing organs. Attention maps highlighting regions of interest for individual patients were assessed. DL models outperformed the conventional NTCP model in both the independent test set (AUC = 0.80-0.84 versus 0.76) and external test set (AUC = 0.73-0.74 versus 0.63) in AUC and calibration. Attention maps showed a focus on the oral cavity and superior pharyngeal constrictor muscle. DL NTCP models performed significantly better than the conventional NTCP model, suggesting the benefit of using 3D-input over the conventional discrete dose parameters. Attention maps highlighted relevant regions linked to dysphagia, supporting the utility of DL for improved predictions.

17 March 2026 in Radiotherapy and Oncology
Verified
Journal Article
Open access
DMD.C. MacRae
D.C. MacRae
LHL. van der Hoek
L. van der Hoek
SVS.P.M. de Vette
S.P.M. de Vette
HNH. Neh
H. Neh
AMAmy Moreno
Amy Moreno
LDL.V. van Dijk
L.V. van Dijk
Toxicities after radiotherapy for head and neck cancer (HNC) often co-occur and share underlying mechanisms, yet most conventional and deep learning (DL) NTCP models predict only a single endpoint. By developing DL NTCP models which can predict multiple toxicities simultaneously, this study aimed to capture inter-toxicity relationships to improve prediction performance. A multi-institutional cohort of 1,418 HNC patients was used to develop and validate a multi-toxicity (MT) DL model, incorporating 3D dose distributions, CT scans, organ-at-risk segmentations and patient-related features, that simultaneously predicts five toxicities; aspiration, dysphagia, sticky saliva, taste alteration and xerostomia, all evaluated six months after treatment. Results are compared to conventional NTCP models, as well as a set of single-toxicity (ST) 3D DL models. The MT model outperformed both the conventional and ST models for dysphagia (AUC = 0.83 versus 0.81 and 0.82) and xerostomia (0.80 versus 0.75 and 0.78) prediction on the independent validation cohort. The latter models achieved better performance for sticky saliva (0.72 and 0.71 versus 0.69) and taste alteration (both 0.67 versus 0.71). The MT model achieved a higher AUC on aspiration than the ST model (0.71), but performed as well as the reference model (both 0.74). Within the external validation cohort, all models performed comparably to each other, with the MT model achieving a slightly higher average AUC (0.64) across all endpoints than the conventional and ST models (both 0.63). Sub-analyses revealed that the benefit of the proposed multi-toxicity modelling varied by endpoint. MT models offer comparable-and in some cases improved-performance over conventional single-endpoint approaches, indicating their promise for NTCP modelling. However, benefits are not uniform across all endpoints, highlighting the importance of considering toxicity-specific features when designing multi-toxicity models.

20 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SVS.P.M. de Vette
S.P.M. de Vette
HNH. Neh
H. Neh
LHL. van der Hoek
L. van der Hoek
DMD.C. MacRae
D.C. MacRae
HCHung Chu
Hung Chu
LDL.V. van Dijk
L.V. van Dijk
Background & purpose Late radiation-associated dysphagia after head and neck cancer (HNC) significantly impacts patient’s health and quality of life. Conventional normal tissue complication probability (NTCP) models use discrete dose parameters to predict toxicity risk but fail to fully capture the complexity of this side effect. Deep learning (DL) offers potential improvements by incorporating 3D dose data for all anatomical structures involved in swallowing. This study aims to enhance dysphagia prediction with 3D DL NTCP models compared to conventional NTCP models. Materials & methods A multi-institutional cohort of 1484 HNC patients was used to train and validate a 3D DL model (Residual Network) incorporating 3D dose distributions, organ-at-risk segmentations, and CT scans, with or without patient- or treatment-related data. Predictions of grade ≥2 dysphagia (CTCAEv4) at six months post-treatment were evaluated using area under the curve (AUC) and calibration curves. Results were compared to a conventional NTCP model based on pre-treatment dysphagia, tumour location, and mean dose to swallowing organs. Attention maps highlighting regions of interest for individual patients were assessed. Results DL models outperformed the conventional NTCP model in both the independent test set (AUC=0.80-0.84 versus 0.76) and external test set (AUC=0.73-0.74 versus 0.63) in AUC and calibration. Attention maps showed a focus on the oral cavity and superior pharyngeal constrictor muscle. Conclusion DL NTCP models performed better than the conventional NTCP model, suggesting the benefit of using 3D-input over the conventional discrete dose parameters. Attention maps highlighted relevant regions linked to dysphagia, supporting the utility of DL for improved predictions.

21 October 2026 in Oral Oncology
Verified
Journal Article
Open access
HNHendrike Neh
Hendrike Neh
DMDaniel C. MacRae
Daniel C. MacRae
SVSuzanne P.M. de Vette
Suzanne P.M. de Vette
LHLuuk van der Hoek
Luuk van der Hoek
POPeter M.A. van Ooijen
Peter M.A. van Ooijen
LDLisanne V. van Dijk
Lisanne V. van Dijk
Taste alteration is a common post-treatment side effect of head and neck cancer (HNC) radiotherapy. Accurate normal tissue complication probability (NTCP) models can support treatment planning aimed at reducing side effects that impair quality-of-life. Deep learning (DL) offers opportunities to incorporate full 3D dose, CT, and organofinterest (OOI) data. Using a large prospective cohort, this study explores whether CNN and transformerbased DL models can outperform a conventional logistic regression model for predicting taste alteration 6 months after radiotherapy. Data from 972 patients was used, with the endpoint being moderatetosevere patientreported taste alteration at six months (EORTC QLQH&N35). DL models were trained using 3D dose distributions, planning CT, OOI segmentations and clinical features. A conventional NTCP model using oral cavity mean dose, parotid mean dose, and age served as reference. Attention maps were evaluated for the transformer-based DL model to quantify the model attention to specific regions of the head and neck area. In addition, two cropping approaches for the 3D data were compared. The CNN and transformer DL models performed comparable to the reference NTCP model in the test set (Reference: AUC = 0.71; ResNet: AUC = 0.68; TransRP: AUC = 0.71), though calibration was best for the reference model. Shifting the crop improved DL performance and transformer attention focused on supraglottic and submandibular regions. This study showed that the prediction of taste alteration can be achieved using DL models, particularly transformer-based models which, in contrast to CNNs, can account for global features of comprehensive 3D information of dose distribution, CT-images and organs-of-interest segmentations.

10 October 2026 in Radiotherapy and Oncology
Verified
Journal Article
Open access
LHLuuk van der Hoek
Luuk van der Hoek
SVSuzanne P.M. de Vette
Suzanne P.M. de Vette
HNHendrike Neh
Hendrike Neh
DMDaniel C. MacRae
Daniel C. MacRae
JLJohannes A. Langendijk
Johannes A. Langendijk
LDLisanne V. van Dijk
Lisanne V. van Dijk